search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
55 new news items in the last 24 hours
  1. Home
  2. Health

NeoVax(MI) vaccine developed by Dana-Farber Cancer Institute could be approved soon with promising results in boosting immune response in melanoma patients

Lara Maior
whatsapp
facebook
linkedin
x
copy-link copy-link
14 July 2025, 12:39
main event image
Health
Vyacheslav Lopatin / Alamy / Profimedia
google-preference

Always see our news on Google

The clinical trial of the personalized vaccine NeoVax(MI) has shown promising results in the treatment of melanoma, generating a strong immune response. The vaccine contains patient-specific neoantigens and is administered together with standard immunotherapies such as nivolumab and ipilimumab. Scientists observed an increase in immune cells after vaccination, indicating effective immune activation. This innovative approach could significantly improve treatments for skin cancer.

Sources

sursa imagine
Fanatik
Vaccinul contra unui tip agresiv de cancer, la un pas de a intra pe piață. Rezultatele remarcabile dau speranțe pacienților
sursa imagine
Economedia
Consiliul Concurenței analizează tranzacţia prin care Mehiläinen Oy preia rețeaua de centre mediale Regina Maria
sursa imagine
News.ro
Consiliul Concurenţei analizează preluarea Grupului Regina Maria de către Mehiläinen Oy

Latest News

08:54

The Annual Meeting of Romanian Diplomacy starts today. Security, the EU, and the war in the East are the main topics on the event's agenda.

08:30

Interim Minister of Defense, Radu Miruță: "A new government is needed, a government with full powers."

08:25

PSD leaders meet in Sinaia, a day before the start of the autumn parliamentary session / Agenda of discussions

08:07

Serghei Lavrov warns that NATO's activity in the Arctic represents a direct threat to Russia's security: "The risk of incidents is increasing."

07:52

Interim Minister of Defense, Radu Miruță: "I cannot be disappointed, as Minister of Defense, by the President of Romania. I would like the point to be made more concretely regarding those who are guilty."

See more news

NEWS ON THE SAME TOPICS

event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
event image
Health
The pharmaceutical group Minapharm will develop a candidate vaccine against the Bundibugyo Ebola strain, with funding of 16.5 million dollars.
event image
Health
Doctors warn: Melanotan II, promoted on TikTok as a quick solution for tanning, is a danger to skin health.
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
Health
India has authorized the use of the Qdenga vaccine against dengue fever
event image
International
WHO will launch next week in Congo clinical studies for two treatments against Ebola
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Vaccine melanoma skin cancer innovation research oncology

Editor’s Recommendations

main event image
Opinions
1 hour ago
Editorials and opinions

Do the math…

main event image
Politics
46 minutes ago

PSD leaders meet in Sinaia, a day before the start of the autumn parliamentary session / Agenda of discussions

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+1
main event image
Politics
2 hours ago

Interim Minister of Defense, Radu Miruţă: "I do not believe there is any intention for Russia to attack any NATO member country."

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
main event image
Opinions
Yesterday 09:03

Sever Voinescu: How we work

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol